Annual Revenue
$3.90 B
+$236.55 M+6.46%
December 31, 2024
Summary
- As of February 7, 2025, IDXX annual revenue is $3.90 billion, with the most recent change of +$236.55 million (+6.46%) on December 31, 2024.
- During the last 3 years, IDXX annual revenue has risen by +$682.14 million (+21.22%).
- IDXX annual revenue is now at all-time high.
Performance
IDXX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$954.29 M
-$21.25 M-2.18%
December 31, 2024
Summary
- As of February 7, 2025, IDXX quarterly revenue is $954.29 million, with the most recent change of -$21.25 million (-2.18%) on December 31, 2024.
- Over the past year, IDXX quarterly revenue has increased by +$52.69 million (+5.84%).
- IDXX quarterly revenue is now -4.91% below its all-time high of $1.00 billion, reached on June 30, 2024.
Performance
IDXX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$3.90 B
+$52.69 M+1.37%
December 31, 2024
Summary
- As of February 7, 2025, IDXX TTM revenue is $3.90 billion, with the most recent change of +$52.69 million (+1.37%) on December 31, 2024.
- Over the past year, IDXX TTM revenue has increased by +$236.55 million (+6.46%).
- IDXX TTM revenue is now at all-time high.
Performance
IDXX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IDXX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.5% | +5.8% | +6.5% |
3 y3 years | +21.2% | +15.2% | +15.7% |
5 y5 years | +61.9% | +15.2% | +15.7% |
IDXX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +21.2% | -4.9% | +19.1% | at high | +21.2% |
5 y | 5-year | at high | +61.9% | -4.9% | +57.6% | at high | +61.9% |
alltime | all time | at high | >+9999.0% | -4.9% | >+9999.0% | at high | >+9999.0% |
IDEXX Laboratories Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $3.90 B(+6.5%) | $954.29 M(-2.2%) | $3.90 B(+1.4%) |
Sep 2024 | - | $975.54 M(-2.8%) | $3.84 B(+1.6%) |
Jun 2024 | - | $1.00 B(+4.1%) | $3.78 B(+1.6%) |
Mar 2024 | - | $964.10 M(+6.9%) | $3.72 B(+1.7%) |
Dec 2023 | $3.66 B(+8.7%) | $901.60 M(-1.5%) | $3.66 B(+2.0%) |
Sep 2023 | - | $915.53 M(-3.0%) | $3.59 B(+2.1%) |
Jun 2023 | - | $943.63 M(+4.8%) | $3.51 B(+2.4%) |
Mar 2023 | - | $900.20 M(+8.6%) | $3.43 B(+1.9%) |
Dec 2022 | $3.37 B(+4.7%) | $828.57 M(-1.6%) | $3.37 B(+0.8%) |
Sep 2022 | - | $841.66 M(-2.2%) | $3.34 B(+0.9%) |
Jun 2022 | - | $860.55 M(+2.9%) | $3.31 B(+1.1%) |
Mar 2022 | - | $836.55 M(+4.4%) | $3.27 B(+1.8%) |
Dec 2021 | $3.22 B(+18.8%) | $801.09 M(-1.2%) | $3.22 B(+2.6%) |
Sep 2021 | - | $810.42 M(-1.9%) | $3.14 B(+2.9%) |
Jun 2021 | - | $826.14 M(+6.2%) | $3.05 B(+6.6%) |
Mar 2021 | - | $777.71 M(+7.9%) | $2.86 B(+5.6%) |
Dec 2020 | $2.71 B(+12.5%) | $720.94 M(-0.1%) | $2.71 B(+4.5%) |
Sep 2020 | - | $721.79 M(+13.2%) | $2.59 B(+4.7%) |
Jun 2020 | - | $637.59 M(+1.8%) | $2.47 B(+0.7%) |
Mar 2020 | - | $626.34 M(+3.5%) | $2.46 B(+2.1%) |
Dec 2019 | $2.41 B(+8.8%) | $605.45 M(+0.0%) | $2.41 B(+2.4%) |
Sep 2019 | - | $605.30 M(-2.4%) | $2.35 B(+2.6%) |
Jun 2019 | - | $620.10 M(+7.6%) | $2.29 B(+1.7%) |
Mar 2019 | - | $576.06 M(+4.9%) | $2.25 B(+1.7%) |
Dec 2018 | $2.21 B(+12.4%) | $549.39 M(+0.7%) | $2.21 B(+2.0%) |
Sep 2018 | - | $545.45 M(-6.1%) | $2.17 B(+2.5%) |
Jun 2018 | - | $580.75 M(+8.0%) | $2.12 B(+3.5%) |
Mar 2018 | - | $537.66 M(+6.2%) | $2.04 B(+3.8%) |
Dec 2017 | $1.97 B(+10.9%) | $506.12 M(+2.9%) | $1.97 B(+3.3%) |
Sep 2017 | - | $491.98 M(-3.3%) | $1.91 B(+2.3%) |
Jun 2017 | - | $508.94 M(+10.2%) | $1.86 B(+2.3%) |
Mar 2017 | - | $462.02 M(+4.3%) | $1.82 B(+2.5%) |
Dec 2016 | $1.78 B(+10.8%) | $443.00 M(-1.2%) | $1.78 B(+2.5%) |
Sep 2016 | - | $448.31 M(-3.9%) | $1.73 B(+2.5%) |
Jun 2016 | - | $466.57 M(+11.7%) | $1.69 B(+3.3%) |
Mar 2016 | - | $417.55 M(+4.5%) | $1.64 B(+2.2%) |
Dec 2015 | $1.60 B(+7.8%) | $399.69 M(-1.6%) | $1.60 B(+3.1%) |
Sep 2015 | - | $406.39 M(-1.7%) | $1.55 B(+1.5%) |
Jun 2015 | - | $413.34 M(+8.1%) | $1.53 B(+1.5%) |
Mar 2015 | - | $382.48 M(+8.7%) | $1.51 B(+1.5%) |
Dec 2014 | $1.49 B(+7.9%) | $351.96 M(-8.2%) | $1.49 B(-0.1%) |
Sep 2014 | - | $383.52 M(-1.7%) | $1.49 B(+3.1%) |
Jun 2014 | - | $390.12 M(+8.3%) | $1.44 B(+2.7%) |
Mar 2014 | - | $360.20 M(+1.7%) | $1.41 B(+2.0%) |
Dec 2013 | $1.38 B(+6.5%) | $354.07 M(+4.7%) | $1.38 B(+2.6%) |
Sep 2013 | - | $338.30 M(-4.1%) | $1.34 B(+1.7%) |
Jun 2013 | - | $352.58 M(+6.2%) | $1.32 B(+1.3%) |
Mar 2013 | - | $332.11 M(+3.9%) | $1.30 B(+0.7%) |
Dec 2012 | $1.29 B(+6.1%) | $319.54 M(+1.3%) | $1.29 B(+1.0%) |
Sep 2012 | - | $315.48 M(-6.0%) | $1.28 B(+1.1%) |
Jun 2012 | - | $335.65 M(+4.0%) | $1.27 B(+1.4%) |
Mar 2012 | - | $322.68 M(+5.0%) | $1.25 B(+2.5%) |
Dec 2011 | $1.22 B(+10.4%) | $307.20 M(+2.1%) | $1.22 B(+2.0%) |
Sep 2011 | - | $300.95 M(-5.3%) | $1.20 B(+2.7%) |
Jun 2011 | - | $317.86 M(+8.6%) | $1.16 B(+3.2%) |
Mar 2011 | - | $292.67 M(+3.1%) | $1.13 B(+2.2%) |
Dec 2010 | $1.10 B(+7.0%) | $283.76 M(+5.2%) | $1.10 B(+1.2%) |
Sep 2010 | - | $269.63 M(-4.2%) | $1.09 B(+1.0%) |
Jun 2010 | - | $281.48 M(+4.8%) | $1.08 B(+1.5%) |
Mar 2010 | - | $268.52 M(-0.7%) | $1.06 B(+3.1%) |
Dec 2009 | $1.03 B(+0.7%) | $270.33 M(+4.3%) | $1.03 B(+2.7%) |
Sep 2009 | - | $259.12 M(-2.5%) | $1.00 B(+0.8%) |
Jun 2009 | - | $265.72 M(+12.4%) | $996.56 M(-1.5%) |
Mar 2009 | - | $236.46 M(-2.8%) | $1.01 B(-1.2%) |
Dec 2008 | $1.02 B(+11.0%) | $243.29 M(-3.1%) | $1.02 B(-0.2%) |
Sep 2008 | - | $251.09 M(-10.5%) | $1.03 B(+2.2%) |
Jun 2008 | - | $280.57 M(+12.6%) | $1.00 B(+4.5%) |
Mar 2008 | - | $249.07 M(+1.7%) | $960.47 M(+4.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | $922.55 M(+24.8%) | $244.97 M(+6.8%) | $922.55 M(+6.1%) |
Sep 2007 | - | $229.38 M(-3.2%) | $869.79 M(+5.1%) |
Jun 2007 | - | $237.05 M(+12.3%) | $827.79 M(+5.8%) |
Mar 2007 | - | $211.16 M(+9.9%) | $782.11 M(+5.8%) |
Dec 2006 | $739.12 M(+15.8%) | $192.21 M(+2.6%) | $739.12 M(+3.5%) |
Sep 2006 | - | $187.38 M(-2.1%) | $713.88 M(+4.3%) |
Jun 2006 | - | $191.36 M(+13.8%) | $684.57 M(+4.7%) |
Mar 2006 | - | $168.16 M(+0.7%) | $653.83 M(+2.5%) |
Dec 2005 | $638.10 M(+16.2%) | $166.97 M(+5.6%) | $638.10 M(+3.7%) |
Sep 2005 | - | $158.07 M(-1.6%) | $615.40 M(+4.1%) |
Jun 2005 | - | $160.63 M(+5.4%) | $591.44 M(+4.1%) |
Mar 2005 | - | $152.43 M(+5.7%) | $568.19 M(+3.5%) |
Dec 2004 | $549.18 M(+15.4%) | $144.27 M(+7.6%) | $549.18 M(+3.7%) |
Sep 2004 | - | $134.11 M(-2.4%) | $529.75 M(+2.7%) |
Jun 2004 | - | $137.38 M(+3.0%) | $515.70 M(+3.1%) |
Mar 2004 | - | $133.42 M(+6.9%) | $500.16 M(+5.1%) |
Dec 2003 | $475.99 M(+15.3%) | $124.84 M(+4.0%) | $475.99 M(+4.1%) |
Sep 2003 | - | $120.06 M(-1.5%) | $457.05 M(+3.5%) |
Jun 2003 | - | $121.85 M(+11.5%) | $441.52 M(+3.8%) |
Mar 2003 | - | $109.25 M(+3.2%) | $425.37 M(+3.1%) |
Dec 2002 | $412.67 M(+6.9%) | $105.89 M(+1.3%) | $412.67 M(+2.7%) |
Sep 2002 | - | $104.53 M(-1.1%) | $401.91 M(+1.8%) |
Jun 2002 | - | $105.69 M(+9.5%) | $394.89 M(+0.9%) |
Mar 2002 | - | $96.55 M(+1.5%) | $391.21 M(+1.3%) |
Dec 2001 | $386.08 M(+5.1%) | $95.13 M(-2.5%) | $386.08 M(+0.7%) |
Sep 2001 | - | $97.52 M(-4.4%) | $383.57 M(+1.9%) |
Jun 2001 | - | $102.00 M(+11.6%) | $376.43 M(+2.3%) |
Mar 2001 | - | $91.43 M(-1.3%) | $367.98 M(+0.1%) |
Dec 2000 | $367.43 M(+2.5%) | $92.62 M(+2.5%) | $367.43 M(+0.5%) |
Sep 2000 | - | $90.38 M(-3.4%) | $365.61 M(+1.1%) |
Jun 2000 | - | $93.55 M(+2.9%) | $361.63 M(+0.6%) |
Mar 2000 | - | $90.88 M(+0.1%) | $359.58 M(+0.4%) |
Dec 1999 | $358.40 M(+12.0%) | $90.80 M(+5.1%) | $358.30 M(+2.3%) |
Sep 1999 | - | $86.40 M(-5.6%) | $350.30 M(+2.3%) |
Jun 1999 | - | $91.50 M(+2.1%) | $342.40 M(+3.2%) |
Mar 1999 | - | $89.60 M(+8.2%) | $331.80 M(+3.7%) |
Dec 1998 | $320.00 M(+21.7%) | $82.80 M(+5.5%) | $320.00 M(+3.6%) |
Sep 1998 | - | $78.50 M(-3.0%) | $309.00 M(+2.3%) |
Jun 1998 | - | $80.90 M(+4.0%) | $302.20 M(+7.9%) |
Mar 1998 | - | $77.80 M(+8.4%) | $280.20 M(+6.6%) |
Dec 1997 | $263.00 M(-1.8%) | $71.80 M(+0.1%) | $262.90 M(-1.1%) |
Sep 1997 | - | $71.70 M(+21.7%) | $265.70 M(+0.7%) |
Jun 1997 | - | $58.90 M(-2.6%) | $263.80 M(-2.6%) |
Mar 1997 | - | $60.50 M(-18.9%) | $270.80 M(+1.2%) |
Dec 1996 | $267.70 M(+41.9%) | $74.60 M(+6.9%) | $267.70 M(+8.2%) |
Sep 1996 | - | $69.80 M(+5.9%) | $247.30 M(+9.3%) |
Jun 1996 | - | $65.90 M(+14.8%) | $226.20 M(+9.4%) |
Mar 1996 | - | $57.40 M(+5.9%) | $206.80 M(+9.7%) |
Dec 1995 | $188.60 M(+49.2%) | $54.20 M(+11.3%) | $188.60 M(+10.7%) |
Sep 1995 | - | $48.70 M(+4.7%) | $170.40 M(+10.9%) |
Jun 1995 | - | $46.50 M(+18.6%) | $153.60 M(+11.1%) |
Mar 1995 | - | $39.20 M(+8.9%) | $138.20 M(+9.3%) |
Dec 1994 | $126.40 M(+35.8%) | $36.00 M(+12.9%) | $126.40 M(+7.8%) |
Sep 1994 | - | $31.90 M(+2.6%) | $117.20 M(+7.4%) |
Jun 1994 | - | $31.10 M(+13.5%) | $109.10 M(+7.9%) |
Mar 1994 | - | $27.40 M(+2.2%) | $101.10 M(+8.5%) |
Dec 1993 | $93.10 M(+61.4%) | $26.80 M(+12.6%) | $93.20 M(+12.6%) |
Sep 1993 | - | $23.80 M(+3.0%) | $82.80 M(+12.3%) |
Jun 1993 | - | $23.10 M(+18.5%) | $73.70 M(+12.7%) |
Mar 1993 | - | $19.50 M(+18.9%) | $65.40 M(+13.3%) |
Dec 1992 | $57.70 M(+89.2%) | $16.40 M(+11.6%) | $57.70 M(+14.0%) |
Sep 1992 | - | $14.70 M(-0.7%) | $50.60 M(+16.6%) |
Jun 1992 | - | $14.80 M(+25.4%) | $43.40 M(+20.6%) |
Mar 1992 | - | $11.80 M(+26.9%) | $36.00 M(+18.0%) |
Dec 1991 | $30.50 M | $9.30 M(+24.0%) | $30.50 M(+43.9%) |
Sep 1991 | - | $7.50 M(+1.4%) | $21.20 M(+54.7%) |
Jun 1991 | - | $7.40 M(+17.5%) | $13.70 M(+117.5%) |
Mar 1991 | - | $6.30 M | $6.30 M |
FAQ
- What is IDEXX Laboratories annual revenue?
- What is the all time high annual revenue for IDEXX Laboratories?
- What is IDEXX Laboratories annual revenue year-on-year change?
- What is IDEXX Laboratories quarterly revenue?
- What is the all time high quarterly revenue for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly revenue year-on-year change?
- What is IDEXX Laboratories TTM revenue?
- What is the all time high TTM revenue for IDEXX Laboratories?
- What is IDEXX Laboratories TTM revenue year-on-year change?
What is IDEXX Laboratories annual revenue?
The current annual revenue of IDXX is $3.90 B
What is the all time high annual revenue for IDEXX Laboratories?
IDEXX Laboratories all-time high annual revenue is $3.90 B
What is IDEXX Laboratories annual revenue year-on-year change?
Over the past year, IDXX annual revenue has changed by +$236.55 M (+6.46%)
What is IDEXX Laboratories quarterly revenue?
The current quarterly revenue of IDXX is $954.29 M
What is the all time high quarterly revenue for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly revenue is $1.00 B
What is IDEXX Laboratories quarterly revenue year-on-year change?
Over the past year, IDXX quarterly revenue has changed by +$52.69 M (+5.84%)
What is IDEXX Laboratories TTM revenue?
The current TTM revenue of IDXX is $3.90 B
What is the all time high TTM revenue for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM revenue is $3.90 B
What is IDEXX Laboratories TTM revenue year-on-year change?
Over the past year, IDXX TTM revenue has changed by +$236.55 M (+6.46%)